Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Publications

Selected References

  • CDC. Giardiasis Surveillance — United States, 2009–2010. 2012;61(SS05):13-23.
  • Yoder JS, Harral C, Beach MJ. Giardiasis surveillance - United States, 2006-2008. MMWR Surveill Summ. Jun 11 2010;59(6):15-25.
  • Robertson LJ, Hanevik K, Escobedo AA, Morch K, Langeland N. Giardiasis--why do the symptoms sometimes never stop? Trends Parasitol. Feb 2010;26(2):75-82.
  • Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis. 2010;4(5):e682.
  • Drugs for Parasitic Infections: The Medical Letter; 2010.
  • Botero-Garces JH, Garcia-Montoya GM, Grisales-Patino D, Aguirre-Acevedo DC, Alvarez-Uribe MC. Giardia intestinalis and nutritional status in children participating in the complementary nutrition program, Antioquia, Colombia, May to October 2006. Rev Inst Med Trop Sao Paulo. May-Jun 2009;51(3):155-162.
  • Muller J, Ley S, Felger I, Hemphill A, Muller N. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother. Jul 2008;62(1):72-82.
  • Naumova EN, Jagai JS, Matyas B, DeMaria A, Jr., MacNeill IB, Griffiths JK. Seasonality in six enterically transmitted diseases and ambient temperature. Epidemiol Infect. Feb 2007;135(2):281-292.
  • Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother. Aug 2007;8(12):1885-1902.
  • Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am. Jun 2006;35(2):291-314, viii.
  • Clinical and Laboratory Standards Institute. Procedures for the recovery and identification of parasites from the intestinal tract; approved guideline. CLSI document M28-A2. 2nd ed. Wayne, PA: Clinical Laboratory Standards Institute; 2005.
  • Johnston SP, Ballard MM, Beach MJ, Causer L, Wilkins PP. Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens. J Clin Microbiol. Feb 2003;41(2):623-626.
  • Stuart JM, Orr HJ, Warburton FG, et al. Risk factors for sporadic giardiasis: a case-control study in southwestern England. Emerg Infect Dis. Feb 2003;9(2):229-233.
  • Berkman DS, Lescano AG, Gilman RH, Lopez SL, Black MM. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet. Feb 16 2002;359(9306):564-571.
  • Newman RD, Moore SR, Lima AA, Nataro JP, Guerrant RL, Sears CL. A longitudinal study of Giardia lamblia infection in north-east Brazilian children. Trop Med Int Health. Aug 2001;6(8):624-634.
  • Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. Jan 2001;14(1):114-128.
  • Borman P, Seckin U, Ozoran K. Beaver fever--a rare cause of reactive arthritis. J Rheumatol. Mar 2001;28(3):683.
  • Hoque ME, Hope VT, Scragg R, Kjellstrom T, Lay-Yee R. Nappy handling and risk of giardiasis. Lancet. Mar 31 2001;357(9261):1017-1018.
  • Pakianathan MR, McMillan A. Intestinal protozoa in homosexual men in Edinburgh. Int J STD AIDS. Dec 1999;10(12):780-784.
  • Hill DR. Giardia lamblia. In: Gillespie SH, Pearson RD, eds. Principles and practice of clinical parasitology. Chisester, England: Joan Wiley & Sons; 2001.
  • Naumova EN, Chen JT, Griffiths JK, Matyas BT, Estes-Smargiassi SA, Morris RD. Use of passive surveillance data to study temporal and spatial variation in the incidence of giardiasis and cryptosporidiosis. Public Health Rep. Sep-Oct 2000;115(5):436-447.
  • Thompson RC. Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol. Nov 2000;30(12-13):1259-1267.
  • Welch TP. Risk of giardiasis from consumption of wilderness water in North America: a systematic review of epidemiologic data. Int J Infect Dis. 2000;4(2):100-103.
  • Greig JD, Michel P, Wilson JB, et al. A descriptive analysis of giardiasis cases reported in Ontario, 1990-1998. Can J Public Health. Sep-Oct 2001;92(5):361-365.
  • Esfandiari A, Swartz J, Teklehaimanot S. Clustering of giardiosis among AIDS patients in Los Angeles County. Cell Mol Biol (Noisy-le-grand). Nov 1997;43(7):1077-1083.
  • Farthing MJ. Giardiasis. Gastroenterol Clin North Am. Sep 1996;25(3):493-515.
  • Kappus KD, Lundgren RG, Jr., Juranek DD, Roberts JM, Spencer HC. Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg. Jun 1994;50(6):705-713.
  • Upcroft JA, Upcroft P. Drug resistance and Giardia. Parasitol Today. May 1993;9(5):187-190.
  • Farthing MJ. Giardia comes of age: progress in epidemiology, immunology and chemotherapy. J Antimicrob Chemother. Nov 1992;30(5):563-566.
  • Wolfe MS. Giardiasis. Clin Microbiol Rev. Jan 1992;5(1):93-100.
  • Sullivan PB, Marsh MN, Phillips MB, et al. Prevalence and treatment of giardiasis in chronic diarrhoea and malnutrition. Arch Dis Child. Mar 1991;66(3):304-306.
  • Birkhead G, Vogt RL. Epidemiologic surveillance for endemic Giardia lamblia infection in Vermont. The roles of waterborne and person-to-person transmission. Am J Epidemiol. Apr 1989;129(4):762-768.
  • Nash TE, Herrington DA, Losonsky GA, Levine MM. Experimental human infections with Giardia lamblia. J Infect Dis. Dec 1987;156(6):974-984.
  • Farthing MJ, Mata L, Urrutia JJ, Kronmal RA. Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth. Am J Clin Nutr. Mar 1986;43(3):395-405.
  • Solomons NW. Giardiasis: nutritional implications. Rev Infect Dis. Jul-Aug 1982;4(4):859-869.
  • Danciger M, Lopez M. Numbers of Giardia in the feces of infected children. Am J Trop Med Hyg. Mar 1975;24(2):237-242.
  • Notis WM. Giardiasis and vitamin B 12 malabsorption. Gastroenterology. Dec 1972;63(6):1085.
  • Rendtorff RC. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg. Mar 1954;59(2):209-220.

Back To Top

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
  • Page last reviewed: September 11, 2012
  • Page last updated: September 11, 2012
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO